Claes R. Andersson

发表

Brunn: An open source laboratory information system for microplates with a graphical plate layout design process

Ola Spjuth, Jonathan Alvarsson, Jarl E. S. Wikberg, 2011, BMC Bioinformatics.

Bayesian detection of periodic mRNA time profiles without use of training examples

Mats G. Gustafsson, Anders Isaksson, Claes R. Andersson, 2006, BMC Bioinformatics.

In Vitro Drug Sensitivity-Gene Expression Correlations Involve a Tissue of Origin Dependency

Mårten Fryknäs, Rolf Larsson, Mats G. Gustafsson, 2007, J. Chem. Inf. Model..

Improving Bayesian credibility intervals for classifier error rates using maximum entropy empirical priors

Hanna Göransson, Mårten Fryknäs, Mats G. Gustafsson, 2010, Artif. Intell. Medicine.

Self-tuning density estimation based on Bayesian averaging of adaptive kernel density estimations yields state-of-the-art performance

Mats G. Gustafsson, Claes R. Andersson, Christofer L. Bäcklin, 2018, Pattern Recognit..

Revealing cell cycle control by combining model-based detection of periodic expression with novel cis-regulatory descriptors

Jan Komorowski, Torgeir R. Hvidsten, Mats G. Gustafsson, 2007, BMC Systems Biology.

Large-scale ligand-based predictive modelling using support vector machines

Ola Spjuth, Jonathan Alvarsson, Jarl E. S. Wikberg, 2016, Journal of Cheminformatics.

Benchmarking Study of Parameter Variation When Using Signature Fingerprints Together with Support Vector Machines

Ola Spjuth, Lars Carlsson, Jonathan Alvarsson, 2014, J. Chem. Inf. Model..

Single-cell transcriptional pharmacodynamics of trifluridine in a tumor-immune model

Claes R. Andersson, M. Jarvius, C. Andersson, 2022, Scientific Reports.

Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing

Claes R. Andersson, K. Blom, R. Larsson, 2018, Oncotarget.

The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation

Claes R. Andersson, M. Jarvius, K. Blom, 2017, Immunopharmacology and immunotoxicology.

Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance

Claes R. Andersson, G. Westman, S. Linder, 2013, BMC Cancer.

Targeting tumor cells based on Phosphodiesterase 3A expression

Claes R. Andersson, M. Nazir, M. Jarvius, 2017, Experimental cell research.

Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy

Jonathan Alvarsson, Rolf Larsson, Claes R. Andersson, 2016, Journal of laboratory automation.

Fusing Domain Knowledge with Data : Applications in Bioinformatics

Claes Andersson, Claes R. Andersson, C. Andersson, 2008 .

Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death

Claes R. Andersson, M. Jarvius, C. Andersson, 2023, BMC Cancer.

Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma

Claes R. Andersson, C. Bréchot, M. Jarvius, 2022, Scientific Reports.

In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index

Claes R. Andersson, M. Kashif, C. Andersson, 2015, Scientific Reports.

A strand specific high resolution normalization method for chip-sequencing data employing multiple experimental control measurements

Claes R. Andersson, J. Komorowski, Stefan Enroth, 2012, Algorithms for Molecular Biology.

Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment

Claes R. Andersson, M. Jarvius, M. Fryknäs, 2024, BMC Pharmacology and Toxicology.

Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.

Claes R. Andersson, M. Höglund, A. Österroos, 2016, Biochemical pharmacology.